Divergent effects of hyper- and hypoglycemia on circulating vascular endothelial growth factor in humans

Metabolism: Clinical and Experimental

Volumn 57, Issue 1, 2008, Pages 90-94

  Oltmanns, Kerstin M ^a   Melchert, Uwe H ^a   Scholand Engler, Harald G ^a   Schultes, Bernd ^a   Schweiger, Ulrich ^a   Peters, Achim ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; VASCULOTROPIN;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DIABETES MELLITUS; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; GLUCOSE BRAIN LEVEL; HORMONAL REGULATION; HUMAN; HUMAN EXPERIMENT; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; MALE; NEUROPROTECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY MECHANISM; UPREGULATION;

ADULT; BLOOD GLUCOSE; EPINEPHRINE; HUMANS; HYDROCORTISONE; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN; MALE; NOREPINEPHRINE; REFERENCE VALUES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 36849081396     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.07.022     Document Type: Article

References (25)

1. Ferrara N., and Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 18 (1997) 4-25
2. Shweiki D., Itin A., Soffer D., et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359 (1992) 843-845
3. Shweiki D., Neeman M., Itin A., et al. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc Natl Acad Sci U S A 92 (1995) 768-772
4. Sone H., Kawakami Y., Okuda Y., et al. Vascular endothelial growth factor is induced by long-term high glucose concentration and up-regulated by acute glucose deprivation in cultured bovine retinal pigmented epithelial cells. Biochem Biophys Res Commun 221 (1996) 193-198
5. Satake S., Kuzuya M., Miura H., et al. Up-regulation of vascular endothelial growth factor in response to glucose deprivation. Biol Cell 90 (1998) 161-168
6. Park S.H., Kim K.W., Lee Y.S., et al. Hypoglycemia-induced VEGF expression is mediated by intracellular Ca2+ and protein kinase C signaling pathway in HepG2 human hepatoblastoma cells. Int J Mol Med 7 (2001) 91-96
7. Natarajan R., Bai W., Lanting L., et al. Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells. Am J Physiol 273 (1997) H2224-H2231
8. Kim N.H., Jung H.H., Cha D.R., et al. Expression of vascular endothelial growth factor in response to high glucose in rat mesangial cells. J Endocrinol 165 (2000) 617-624
9. Iglesias-de la Cruz M.C., Ziyadeh F.N., Isono M., et al. Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes. Kidney Int 62 (2002) 901-913
10. Evans J.L., Goldfine I.D., Maddux B.A., et al. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23 (2002) 599-622
11. Dantz D., Bewersdorf J., Fruehwald-Schultes B., et al. Vascular endothelial growth factor: a novel endocrine defensive response to hypoglycemia. J Clin Endocrinol Metab 87 (2002) 835-840
12. Merl V., Peters A., Oltmanns K.M., et al. Antecedent hypoglycaemia attenuates vascular endothelial growth factor response to subsequent hypoglycaemia in healthy men. Diabet Med 22 (2005) 1278-1281
13. Oltmanns K.M., Gehring H., Rudolf S., et al. Acute hypoxia decreases plasma VEGF concentration in healthy humans. Am J Physiol Endocrinol Metab 290 (2006) E434-E439
14. Williamson J.R., Chang K., Frangos M., et al. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42 (1993) 801-813
15. Duh E., and Aiello L.P. Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Diabetes 48 (1999) 1899-1906
16. Malik R.A., Li C., Aziz W., et al. Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy. J Cell Mol Med 9 (2005) 692-697
17. Hubold C., Oltmanns K.M., Schultes B., et al. High plasma VEGF relates to low carbohydrate intake in patients with type 2 diabetes. Int J Obes (Lond) 30 (2006) 1356-1361
18. Lerman O.Z., Galiano R.D., Armour M., et al. Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia. Am J Pathol 162 (2003) 303-312
19. Harmey J.H., and Bouchier-Hayes D. Vascular endothelial growth factor (VEGF), a survival factor for tumour cells: implications for anti-angiogenic therapy. Bioessays 24 (2002) 280-283
20. Freedman S.B., and Isner J.M. Therapeutic angiogenesis for coronary artery disease. Ann Intern Med 136 (2002) 54-71
21. Imagawa S., Yamaguchi Y., Higuchi M., et al. Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea-hypopnea syndrome. Blood 98 (2001) 1255-1257
22. Sone H., Deo B.K., and Kumagai A.K. Enhancement of glucose transport by vascular endothelial growth factor in retinal endothelial cells. Invest Ophthalmol Vis Sci 41 (2000) 1876-1884
23. Mani N., Khaibullina A., Krum J.M., et al. Activation of receptor-mediated angiogenesis and signaling pathways after VEGF administration in fetal rat CNS explants. J Cereb Blood Flow Metab 23 (2003) 1420-1429
24. Peters A., Schweiger U., Pellerin L., et al. The selfish brain: competition for energy resources. Neurosci Biobehav Rev 28 (2004) 143-180
25. Yla-Herttuala S., Rissanen T.T., Vajanto I., et al. Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine. J Am Coll Cardiol 49 (2007) 1015-1026